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A 10-week-old 0.73-kg (1.6-lb) castrated male do-mestic ferret (Mustela putorius furo) was re-
ferred to the Exotic Animal Clinical Service of the 
Veterinary Teaching Hospital at the University of 
Montréal for exploratory laparotomy because of 
pneumoperitoneum and possible septic peritonitis 
after being bitten by the owner’s dog.
The ferret had been evaluated by the referring vet-
erinarian a few hours after the traumatic incident. On 
physical examination, the patient was lethargic and 
recumbent and had a high-normal rectal temperature 
(39.8°C [103.6°F]; reference range, 37.8° to 40°C [100.4° 
to 104°F]).1 The referring veterinarian observed ab-
dominal distension and ecchymoses, but no associated 
penetrating bite wounds. Abdominal palpation elicited 
signs of pain. Initial stabilization by the referring vet-
erinarian included IV crystalloid fluid therapya (8 to 
12 mL/kg/h [3.6 to 5.5 mL/lb/h]) and analgesia (hydro-
morphone, 0.1 mg/kg [0.045 mg/lb], IV, q 4 h). Survey 
radiography revealed loss of abdominal serosal detail 
consistent with abdominal effusion, free air in the ab-
domen, loss of integrity of the right abdominal wall 
with apparent herniation of the small intestines into 
the subcutaneous tissues, and contusions involving the 
right middle lung lobe. Given the patient’s history and 
the results of physical examination and radiography, 
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CASE DESCRIPTION
A 10-week-old 0.73-kg (1.6-lb) castrated male domestic ferret (Mustela puto-
rius furo) was referred for exploratory laparotomy because of pneumoperi-
toneum and possible septic peritonitis after being bitten by the owner’s dog.
CLINICAL FINDINGS
Abdominal exploration revealed a large laceration of the duodenum, tears 
of the jejunal mesentery, and 2 small tears in the abdominal wall. Chylous 
abdominal effusion developed 48 hours after surgery.
TREATMENT AND OUTCOME
Postoperative care included supportive treatment, analgesia, and antimi-
crobials. An abdominal drain was placed during the laparotomy and enabled 
monitoring of abdominal fluid production. Enteral feeding was provided 
through an esophagostomy tube. The chylous fluid production rapidly de-
creased after treatment with octreotide was initiated, and the ferret im-
proved. Chyloabdomen resolved after 8 days of hospitalization and medical 
treatment.
CLINICAL RELEVANCE
Findings suggested that chylous ascites can potentially develop secondary 
to blunt abdominal trauma in ferrets. In this ferret, chyloabdomen was suc-
cessfully treated with octreotide administration and abdominal drainage. 
( J Am Vet Med Assoc 2018;252:1272–1278)
the referring veterinarian suspected the patient had 
a traumatic abdominal wall tear and perforation of a 
hollow viscus, resulting in septic peritonitis. Contrast 
radiography confirmed the presence of a perforated 
loop of intestine, and the ferret was referred for ex-
ploratory laparotomy and further treatment.
On referral examination, the ferret was stupor-
ous, tachypneic (48 respirations/min; reference 
range, 33 to 36 respirations/min),2 tachycardic (380 
beats/min; reference range, 180 to 250 beats/min),3 
and laterally recumbent, with a rectal temperature 
of 39.9°C (104°F). The mucous membranes were pale 
and lacked observable capillary refill. The abdomen 
was distended, and signs of severe pain were elicited 
on palpation.
A tear involving the right lateral aspect of the ab-
dominal wall was suspected. High-normal rectal tem-
perature was attributed to the septic process because 
the referring veterinarian reported a similar rectal 
temperature before the ferret was transferred, reduc-
ing the likelihood that transportation, stress, or excite-
ment contributed to this finding. Furthermore, the 
history and physical examination findings suggested 
hyperdynamic circulatory shock, a condition that may 
be associated with septic peritonitis.
Indirect blood pressure measured by means of 
Doppler ultrasonography was low (systolic blood pres-
sure, 50 mm Hg; reference range, 80 to 120 mm Hg).4,5 
A CBC and serum biochemical analyses revealed 
a moderately low PCV (31%; reference range, 40% 
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to 70%), markedly high BUN concentration (29.5 
mmol/L; reference range, 4.8 to 16.9 mmol/L), and 
normal serum creatinine concentration (35 µmol/L; 
reference range, 23.0 to 76.7 µmol/L).6 Moderate 
hypoproteinemia (48 g/L; reference range, 54.7 to 
77.9 g/L)6 was detected and attributed to septic peri-
tonitis and gastrointestinal bleeding secondary to 
abdominal trauma. The patient’s hyponatremia (131 
mmol/L; reference range, 140.1 to 169.7 mmol/L)6 
was most likely caused by third-space fluid accumu-
lation. Blood glucose concentration (8.4 mmol/L; 
reference range, 3.0 to 8.4 mmol/L)6 was within ref-
erence limits.
A focused assessment with sonography for trau-
ma was performed on the abdomen and revealed 
hyperechoic peritoneal effusion and small intestines 
distended with fluid. Further, no peristaltic move-
ment was observed, consistent with generalized in-
testinal ileus.
For stabilization and in preparation for an emer-
gency exploratory laparotomy, enrofloxacin (10 mg/
kg [4.5 mg/lb]) and a bolus of lactated Ringer solu-
tionb (10 mL/kg) were administered IV. The ferret’s 
heart rate decreased to 250 beats/min, and capillary 
refill time could now be assessed but was prolonged 
(< 3 seconds; reference range, ≤ 2 seconds).7 
The ferret was premedicated with midazolam 
(0.3 mg/kg [0.14 mg/lb], IV) and fentanyl (8 µg/
kg, IV) and was preoxygenated for 5 minutes via 
facemask. Anesthesia was induced with ketamine 
(5 mg/kg [2.3 mg/lb], IV), and the ferret was in-
tubated with a cuffed endotracheal tube that had 
an inner diameter of 3 mm. Anesthesia was main-
tained with isoflurane, and intraoperative moni-
toring included capnography, ECG, and pulse ox-
imetry performed with a multiparameter patient 
monitor.c Analgesia was provided with infusions 
of fentanyl (5 to 10 µg/kg/h, IV) and lidocaine 
(25 µg/kg/min [11.4 µg/lb/min], IV). Because of 
the septic shock and to improve blood pressure, a 
phenylephrine (1 to 2 µg/kg/min [0.45 to 0.9 µg/
lb/min], IV) infusion was initiated at the time of 
anesthetic induction, and boluses of hydroxyethyl 
starchd (5 mL/kg, IV, divided over 3 boluses) and 
lactated Ringer solutionb (5 mL/kg, IV) were ad-
ministered. Placement of an arterial catheter for 
direct blood pressure measurements was unsuc-
cessful, and a decision was made to monitor the 
patient’s blood pressure indirectly by the oscil-
lometric method. Because only a single measure-
ment (systolic blood pressure, 90 mm Hg for 2 
hours after anesthetic induction) was successfully 
obtained during the anesthetic procedure, the pa-
tient’s heart rate was used as an indirect indicator 
of blood pressure for intraoperative fluid therapy 
decisions. Factors that contributed to unsuccess-
ful monitoring of blood pressure by the oscillo-
metric method included the patient’s severe hy-
potension and the limited intraoperative access to 
perform these measurements.
A ventral midline laparotomy was performed. 
The abdomen contained serosanguineous fluid mixed 
with what appeared to be greenish intestinal contents 
(Figure 1). A sample of the fluid was obtained for 
Figure 1—Intraoperative photographs obtained during 
exploratory laparotomy in a 10-week-old domestic ferret 
(Mustela putorius furo) that had been bitten by a dog. A—The 
abdominal cavity contained serosanguineous fluid mixed with 
intestinal contents. B—The jejunum was dilated, suggestive of 
paralytic ileus, and a laceration of the descending duodenum 
(arrow) was observed. C—The cranial right aspect of the ab-
domen had an abdominal wall perforation (arrow) next to the 
right kidney (asterisk).
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aerobic and anaerobic bacterial culture. The descend-
ing duodenum had a large laceration perforating the 
mesenteric and antimesenteric aspects 1 cm distal to 
the major duodenal papilla. Several small mesenteric 
tears were present, and a large portion of the jeju-
num appeared dilated and paralyzed. Vascularization 
of the jejunum did not appear to be compromised. 
Two small perforations of the abdominal wall were 
present, one on each side near the right and left kid-
neys. A duodenal resection and anastomosis was per-
formed. The mesenteric tears and the abdominal wall 
perforations were closed. Prior to abdominal closure, 
the abdomen was lavaged with warm sterile saline 
(0.9% NaCl) solution, and a 10-mm Jackson-Pratt sur-
gical draine was placed for postoperative abdominal 
drainage and fluid production monitoring. The anes-
thetic procedure required 4 hours and 30 minutes 
from the time of induction to extubation.
Immediate postoperative intensive care includ-
ed fluid therapy with crystalloid (lactated Ringer 
solution,b 2.5 mL/kg/h [1.1 mL/lb/h], IV) and colloid 
(hydroxyethyl starch,d 1 mL/kg/h, IV) solutions and 
administration of enrofloxacin (10 mg/kg, IV, q 12 h) 
and cefazolin (22 mg/kg [10 mg/lb], IV, q 8 h). Phen-
ylephrine (0.5 µg/kg/min [0.23 µg/lb/min], IV) ad-
ministration was discontinued within the first hour 
after surgery, and the vasopressor, norepinephrine 
(0.1 to 1 µg/kg/min, IV) was administered instead. 
Nevertheless, severe systolic hypotension (35 to 44 
mm Hg) persisted during the first 12 hours after sur-
gery. Analgesia was provided with infusions of fen-
tanyl (1.25 to 5 µg/kg/h [0.57 to 2.3 µg/lb/h], IV) and 
ketamine (0.1 to 0.4 mg/kg/h [0.045 to 0.18 mg/lb/h], 
IV). Constant rate infusions were used to avoid peaks 
and troughs observed with IM administration and to 
enable quick adjustments of dosages on the basis of 
patient requirements. Because hypoglycemia (1.1 to 2 
mmol/L) was noted during anesthesia, blood glucose 
concentration was monitored every 4 to 8 hours. Nor-
epinephrine was administered in 5% dextrose solution 
to prevent further hypoglycemia, and blood glucose con-
centration (3.7 to 8.4 mmol/L) remained within reference 
limits overnight. During the first 12 hours after the surgi-
cal procedure, a substantial volume of serosanguineous 
fluid (6.7 mL/kg/h [3.05 mL/lb/h]) had been collected 
through the abdominal drain. Drain care consisted of 
stabilization of the drainage bulb tubing to the ferret’s 
body with an abdominal bandage and disinfection of the 
tubing and ports with alcohol during each manipulation 
of the apparatus. In the postoperative period, the ferret’s 
hemodynamic status was closely monitored through fre-
quent evaluation of systolic blood pressure by means of 
Doppler ultrasonography, urine output measurements, 
and a continuous ECG.
During the first 24 hours after the surgery, the 
ferret’s general condition mildly improved; however, 
the ferret continued to be hypotensive with systolic 
blood pressure ranging from 60 to 65 mm Hg despite 
continuous infusion of norepinephrine. The ferret was 
stuporous and tachycardic (260 to 280 beats/min). No 
urine or feces were produced overnight. A CBC was 
performed and revealed severe leukopenia (1.36 X 109 
WBCs/L; reference range, 3.0 X 109 WBCs/L to 16.7 X 
109 WBCs/L) due to neutropenia (0.27 X 109 cells/L; 
reference range, 0.9 X 109 cells/L to 7.4 X 109 cells/L).6 
There was a left shift (bands, 0.16 X 109 cells/L; refer-
ence range, 0 to 0.1 X 109 cells/L)6 with toxic changes 
present in the neutrophils consistent with a septic pro-
cess. Serum biochemical analyses revealed a high al-
kaline phosphatase activity (312 U/L; reference range, 
13.3 to 141.6 U/L), consistent with sepsis-induced cho-
lestasis, and severe hypoalbuminemia (11.5 g/L; refer-
ence range, 28.0 to 43.9 g/L) and hypoglobulinemia 
(19.1 g/L; reference range, 20 to 29 g/L),6 consistent 
with loss in the abdominal inflammatory effusion. 
Furthermore, a high creatinine concentration (110 
µmol/L; reference range, 23.0 to 76.7 µmol/L)6 com-
bined with a urine specific gravity (1.040; reference 
range, 1.034 to 1.060)8 within reference limits sug-
gested prerenal azotemia. Therefore, fluid therapy was 
altered from lactated Ringer solutionb to an alkalinizing 
solutiona (10 mL/kg/h, IV) with a slightly higher sodium 
content to maintain the patient’s serum sodium concen-
tration within reference limits.
Given the ferret’s critical state on postoperative 
day 1, further clinical support was provided. General 
anesthesia was induced for placement of a 10F esoph-
agostomy tube and a urinary catheter. The urinary 
catheter was placed to enhance fluid balance moni-
toring by enabling accurate comparisons of the total 
fluids received by all methods to total fluids lost via 
the urinary catheter and abdominal drain. This moni-
toring continued every 4 hours until the urinary cath-
eter was removed on postoperative day 5. Changes 
in fluid balance, body weight, and clinical condition 
were used to make fluid therapy decisions during this 
time. Also on postoperative day 1, additional medi-
cations were started to stimulate gastrointestinal 
motility and aid in tolerance of future enteral feed-
ings (metoclopramide, 2 mg/kg/d, IV), reduce nausea 
(maropitant, 1 mg/kg, IV, q 12 h), and control and 
prevent potential gastritis (famotidine, 0.5 mg/kg, IV, 
q 8 h). At this time, the patient’s analgesic treatment 
consisted of multiple constant rate infusions (fentanyl, 
1.25 to 2 µg/kg/h, IV; ketamine, 0.2 to 0.3 mg/kg/h 
[0.09 to 0.14 mg/lb/h], IV; and lidocaine, 10 µg/kg/
min, IV) to obtain an acceptable level of pain control. 
To broaden the antimicrobial spectrum, metronida-
zole (20 mg/kg [9.1 mg/lb], IV, q 12 h) administration 
was also initiated.
On day 2, treatment continued as previously de-
scribed, and enteral feedingsf through the esopha-
gostomy tube were implemented when the ferret’s 
systolic blood pressure was ≥ 80 mm Hg. Enteral 
feedings were started at a third of the patient’s cal-
culated daily REE, with feedings performed every 2 
hours. Primary goals of the initial enteral feedings 
were to provide nutritional support to the intestinal 
tract and enhance local blood flow to optimize heal-
ing at the surgical sites. Because the ferret had higher 
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urine output (8 mL/kg/h; reference range, 1.08 to 
1.17 mL/kg/h)2 than expected and had developed se-
vere diarrhea, the IV fluid rate was modified such that 
the volume administered by IV and enteral feeding 
equaled the total volume collected through the uri-
nary catheter and abdominal drain.
On day 3, the ferret’s general condition improved 
substantially. The ferret was more alert and respon-
sive and began to move voluntarily in its cage. Heart 
rate, respiratory rate, and rectal temperature were 
within reference ranges, and even though the dos-
age of norepinephrine was decreased (0.7 µg/kg/
min [0.32 µg/lb/min], IV), measurements of systolic 
blood pressure (70 to 105 mm Hg) were within the 
reference range. Monitoring of blood glucose con-
centration revealed hyperglycemia (18.6 mmol/L) 
that was attributed to the use of 5% dextrose as the 
IV fluid delivery solution for the norepinephrine infu-
sion. Therefore, a single dose of a short-acting insuling 
(0.5 U, SC) was administered, the constant rate infu-
sion of norepinephrine in 5% dextrose solution was 
discontinued, and a constant rate infusion of norepi-
nephrine in saline solution was initiated. The ferret 
responded well, and no further episodes of hypergly-
cemia were noted. Analgesic requirements progres-
sively decreased, and administration of fentanyl was 
discontinued, with ongoing analgesia provided with 
ketamine (0.1 mg/kg/h, IV) and lidocaine (10 mg/
kg/h, IV) infusions and the addition of buprenor-
phine (0.02 mg/kg [0.01 mg/lb], IV, q 8 h). Admin-
istration of metoclopramide and antimicrobials was 
continued as previously described. Modifications to 
gastrointestinal support were implemented with the 
substitution of omeprazole (2.5 mg/kg, PO, q 24 h) for 
famotidine and the discontinuation of maropitant. En-
teral feedings via the esophagostomy tube were well 
tolerated, and the volume fed was increased to 50% of 
the patient’s REE. A repeated CBC showed mild ane-
mia (PCV, 33%) that was attributed to hemodilution, 
blood sampling, and inflammation. Neutrophil (6.39 
X 109 cells/L), lymphocyte (3.24 X 109 cells/L; refer-
ence range, 0.6 X 109 cells/L to 10.5 X 109 cells/L),6 
and WBC (10.14 X 109 cells/L) counts were within 
reference ranges; however, a left shift (bands, 0.41 
X 109 cells/L) and toxic changes in the neutrophils 
persisted. Serum biochemical analyses revealed per-
sistent hypoalbuminemia (12.2 g/L) and hypoglobu-
linemia (18.4 g/L), consistent with ongoing loss via 
the digestive tract and the inflammatory processes 
associated with sepsis. Azotemia and hyponatremia 
had resolved. Abdominal fluid production (6 mL/
kg/h [2.7 mL/lb/h]) remained high, and the fluid 
started to take on a cloudy white appearance.
On day 4, abdominal fluid production had in-
creased (8.2 mL/kg/h [3.7 mL/lb/h]), and the fluid 
had a milky appearance (Figure 2). Analysis of the 
fluid was performed, and results were consistent 
with a chylous effusion with nonseptic neutrophilic 
inflammation. Triglyceride concentration in the effu-
sion was 5.99 mmol/L, compared with 0.99 mmol/L 
(reference range, 0.5 to 2.8 mmol/L)6 in the serum. 
The effusion’s total solids concentration, measured 
by refractometry, was 11 g/L, but was artificially high 
because of the high lipid content. Cytologic examina-
tion of the effusion revealed a total cell count of 1.05 
cells/µL, with the predominant cells being lympho-
cytes (43%), nondegenerative neutrophils (38%), and 
monocytes (19%). No microorganisms were seen. On 
the basis of the effusion’s cytologic and biochemical 
analyses results, a chylous effusion was diagnosed. 
Therefore, the enteral feedings were modified to a 
dieth specifically formulated for obligate carnivores 
such as ferrets.
By day 5, the ferret’s clinical condition had im-
proved further. Because of the ferret’s mobility, con-
tinuous ECG and urine production monitoring were 
discontinued; however, the patient still required va-
sopressor support (norepinephrine, 0.4 to 0.7 µg/
kg/min, IV) to maintain blood pressure within the 
reference range. Although the ferret seemed dis-
interested in food offered orally, enteral feedings 
through the esophagostomy tube were well tolerat-
ed, and the patient’s caloric intake through the tube 
was increased to two-thirds of the REE. The patient 
began to have normal-appearing bowel movements. 
Bacterial culture of the abdominal fluid collected 
during surgery revealed growth of Streptococcus 
spp; however, antimicrobial susceptibility testing 
Figure 2—Photograph of abdominal effusion obtained 4 days 
after exploratory laparotomy from the ferret in Figure 1. No-
tice the typical cloudy white appearance suggestive of chyle.
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could not be performed given the fastidious nature 
of the isolate’s growth. Because Streptococcus spp 
are usually susceptible to β-lactams, the antimicro-
bial spectrum was narrowed to IV administration of 
cefazolin (22 mg/kg, IV, q 8 h).
Over the following 48 hours (days 6 and 7), the 
ferret’s clinical condition continued to improve. 
Metoclopramide, ketamine, lidocaine, and norepi-
nephrine IV infusions were discontinued. The crys-
talloid and colloid fluid therapy continued, and the 
patient’s enteral caloric intake was increased to 100% 
of the REE. Because the ferret’s peripheral veins were 
affected by phlebitis at this time and because the fer-
ret had begun to make retching and vomiting efforts, 
presumably as a result of the esophagostomy tube, 
the decision was made to induce general anesthesia 
(midazolam, 0.3 mg/kg, IM; butorphanol, 0.05 mg/kg 
[0.02 mg/lb], IM) for placement of a jugular catheter 
and repositioning of the esophagostomy tube. Posi-
tioning of the esophagostomy tube was confirmed 
radiographically. Abdominal fluid production contin-
ued to be high (up to 12.7 mL/kg/h [5.8 mL/lb/h]); 
therefore, octreotidei (10 µg/kg, SC, q 8 h), a soma-
tostatin analog that has been used successfully in the 
treatment of chylothorax and chylous ascites, was 
initiated to decrease the production of the abdomi-
nal chylous effusion.35,38,39 A CBC revealed a normal 
leukogram, but the lymphocyte count had decreased 
(1.3 X 109 cells/L), compared with the count on day 3, 
likely because of loss in the chylous effusion.
On day 8, the ferret was able to eat on its own, 
but was not able to meet its caloric requirement via 
this route. Fluid therapy consisted of infusion of crys-
talloids (15 to 20 mL/kg/h [6.8 to 9.1 mL/lb/h], IV) 
and colloids (0.4 to 0.7 mL/kg/h, IV). Analgesic and 
antimicrobial treatment consisted of buprenorphine 
and cefazolin, respectively, at the same dosages as 
previously described. The abdominal drain had func-
tioned consistently until day 8, when it suddenly oc-
cluded. The occlusion was confirmed by detaching 
the bulb from the drain and attempting to flush the 
drain with sterile saline solution. This procedure was 
unsuccessful, and because there was evidence of 
continued abdominal effusion on focused assessment 
with sonography for trauma, the decision to place 
a second abdominal drain under general anesthesia 
was made.
Anesthesia was induced with butorphanol (0.05 
mg/kg, IM), midazolam (0.3 mg/kg, IM), and propofol 
(4 mg/kg [1.8 mg/lb], IV). The ferret was then intu-
bated with a cuffed endotracheal tube that had an in-
ner diameter of 3 mm, and anesthesia was maintained 
with isoflurane. The abdominal drain was removed, 
and the entrance site of the drain sutured closed. A 
second abdominal drain, a 12-gauge tube,j was placed 
(Seldinger technique) to provide drainage of the chy-
lous effusion. Abdominal fluid production (3.8 mL/
kg/h [1.7 mL/lb/h]) decreased dramatically within 36 
hours after octreotide administration was begun, and 
the effusion’s appearance became less chylous. Fluid 
therapy was decreased and eventually discontinued, 
and amoxicillin-clavulanate (12.5 mg/kg [5.7 mg/lb], 
PO, q 12 h) replaced IV antimicrobial treatment.
From days 9 to 11, the ferret’s general condition 
continued to improve. Its appetite was considered 
normal, and because the ferret was able to ingest suf-
ficient food orally to meet its REE, the esophagostomy 
tube was removed. Abdominal fluid production con-
tinued to decrease; by day 11, it was 0.2 mL/kg/h, and 
the abdominal drain was removed. Serum biochemi-
cal analyses revealed improvement of the hypoalbu-
minemia (24.4 g/L) and a globulin concentration (24 
g/L) within reference range. Results of hematologic 
evaluation revealed polychromasia and resolution of 
the toxic changes in the neutrophils.
The ferret remained hospitalized for an additional 
24 hours for monitoring and was discharged on day 12 
with instructions for the owner to administer amoxi-
cillin-clavulanate (12.5 mg/kg, PO, q 12 h) for 7 days 
and octreotide (10 µg/kg, SC, q 8 h) for 3 days. Com-
munication with the owner 2 months after surgery in-
dicated that the ferret had continued to do well. Thirty 
months later, no long-term complications associated with 
the traumatic event had been reported by the owner.
Discussion
To the authors’ knowledge, this was the first well-
documented case report in the veterinary medical liter-
ature regarding the development of abdominal chylous 
effusion secondary to abdominal trauma and surgical 
intervention in a ferret. In veterinary medicine, chy-
loabdomen has been reported previously in various spe-
cies, including dogs and cats,9–18 horses,19–24 bovids,25 
slender-tailed meerkats,26 red pandas,27 a cheetah,28 a 
hedgehog,29 and a Djungarian hamster.k On the authors’ 
review of the pertinent veterinary medical literature, 
only 1 published report30 of this condition in ferrets 
was found. Another report31 has been documented in 
the gray literature, and at least 1 clinician has encoun-
tered this condition.l
Chylous ascites is an uncommon cause of ab-
dominal effusion and is usually related to disruption 
of the lymphatic network. In humans, it may arise 
from congenital disorders, but in most cases is sec-
ondary to traumatic injury, obstruction, or external 
compression of the lymphatics, infections, hepatic 
cirrhosis, or inflammatory diseases.32 In veterinary 
medicine, similar causes have been described, in-
cluding suspected congenital defects in a calf25 and 
in a foal,19 neoplasia (the most common cause of 
chylous ascites in cats and the only reported cause 
in ferrets),9,10,12,18,30 steatitis secondary to vitamin E 
deficiency in a cat,10 feline infectious peritonitis,15 
pancreatitis in a dog and slender-tailed meerkats,11,26 
and hepatic cirrhosis.10,28,29 Chylous ascites that de-
veloped in a horse following nephrectomy has been 
described,24 but to the authors’ knowledge, chylous 
ascites secondary to trauma has not been reported in 
the veterinary literature.
In human medicine, postoperative chylous asci-
tes is a rare complication caused by incidental disrup-
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tion of major retroperitoneal lymphatics such as may 
occur during procedures requiring extensive dissec-
tion in the retroperitoneal space or near the root of 
the mesentery. Typically, chylous effusions appear a 
few days to even a month after the surgical proce-
dure.32 In the ferret described in the present report, 
surgery was performed 2 days before the abdominal 
effusion acquired the appearance of chyle. The trau-
matic lesions in the ferret’s abdomen were surgically 
corrected without manipulations or dissections near 
the major retroperitoneal lymphatic network or root 
of the mesentery. The abdominal wall tears second-
ary to trauma were located dorsally in the abdominal 
wall, close to the epaxial muscles and retroperitoneal 
space; however, these tears were small, and no other 
gross abnormalities were seen in the retroperitoneal 
spaces. The abdominal organ lesions were limited to 
the gastrointestinal tract, with the largest perforation 
present in the duodenum. Some perforations were 
also present in the mesentery of the jejunum, but did 
not compromise its vascular supply. Furthermore, no 
gross lesions of the vasculature or root of the mesen-
tery were identified.
From the authors’ perspectives, it was highly un-
likely that iatrogenic surgical disruption of the lymphat-
ic networks caused the chylous effusion. Similarly, oth-
er potential causes, such as congenital malformations, 
malignancy, or rupture of major lymphatic vessels, were 
also deemed unlikely because they typically require sur-
gery to alleviate the chylous ascites.
Although the definitive cause of the ferret’s 
chylous effusion was not identified, blunt abdomi-
nal trauma was suspected given the ferret’s lack of 
clinical signs of disease prior to the traumatic inci-
dent and rapid improvement with medical treatment. 
Blunt abdominal trauma as a cause of chylous asci-
tes is better described in the human pediatric litera-
ture32–34 and accounts for up to 19% of such cases in 
literature reviews. In these children, blunt abdominal 
trauma is believed to cause chyloabdomen as a result 
of hyperextension and hyperflexion of lymphatic 
vessels, leading to rupture of lymphatic vessels and 
lymph leakage.33
Conservative treatment successfully resolved clin-
ical signs of chyloabdomen after 48 hours in the ferret 
described in the present report. In humans, medical 
management is the initial therapeutic approach for 
chylous effusions,32,33,35 with nutritional support being 
an important component to maintain the patient’s nu-
tritional status and influence chyle formation and flow 
through the thoracic duct. Total parenteral nutrition 
is generally advocated, although provision of a high-
protein, low-fat diet with medium-chain triglycerides 
is an alternative.33 Medium-chain triglycerides are ab-
sorbed directly by intestinal cells and then transported 
as glycerol and free fatty acids directly to the liver via 
the portal vein, unlike long-chain triglycerides, which 
are converted into monoglycerides and free fatty acids, 
and then transported as chylomicrons to the intestinal 
lymph ducts.33 Such diets reduce the production and 
flow of chyle in humans33 but do not seem to influence 
chyle production and flow in dogs.m In the ferret de-
scribed in the present report, total parenteral nutrition 
was not recommended because of the need to main-
tain mucosal integrity of the small intestine, encourage 
healing by reversal of mucosal atrophy induced by star-
vation, and increase anastomotic collagen deposition 
and strength.36 An esophagostomy tube was placed to 
support these nutritional goals, and enteral nutrition 
was implemented as soon as the patient’s cardiovascu-
lar status stabilized (day 3). Initially, the ferret received 
a highly digestible, high-protein diete (44.2% on a dry-
matter basis) with a relatively high fat content (30.4% 
fat on a dry-matter basis) at a third of its REE. However, 
once the chyloabdomen was diagnosed, the ferret’s 
diet was changed to a diet specifically formulated for 
obligate carnivores.g Unfortunately, this change did 
not affect the production of chyle.
To decrease the ferret’s production of chyle, a 
synthetic long-acting somatostatin analog, octreotide, 
was administered. Octreotide has broad-ranging ef-
fects on the body, and its use in treating chylous ef-
fusions stems from its effects on the gastrointestinal 
system.35,37 The exact mechanisms are unknown; how-
ever, the drug’s multifactorial effects on the gastroin-
testinal system and reduction in splanchnic blood flow 
are thought to reduce the thoracic duct circulation 
and the triglyceride content of the chyle.35,37 Octreo-
tide has been shown in animals to shorten the time for 
chylous fistula closure and cessation of chylous drain-
age,38 and the use of octreotide is often recommended 
in humans as an adjunct to other treatments for chy-
lous effusions. Octreotide administered via continuous 
IV infusions and SC injections has been used success-
fully in humans, and the IV delivery may drastically 
decrease chylous fistula output after 24 to 72 hours of 
treatment.39 In the ferret described in the present re-
port, chylous effusion was successfully managed medi-
cally with octreotide, administered at a dosage previ-
ously reported in the veterinary literature,40 combined 
with abdominal drainage. Neither advanced imaging 
nor a second surgical intervention was necessary for 
resolution of the chyloabdomen.
Footnotes
a. Plasma-Lyte A, Baxter Inc, Mississauga, ON, Canada.
b. Lactated Ringer solution, Baxter Inc, Mississauga, ON, Canada.
c. Life Window LW6000, DigiCare Animal Health, Boyton 
Beach, Fla.
d. Voluven, Fresenius Kabi Canada, Calea Ltd, Mississauga, ON, 
Canada.
e. Jackson-Pratt silicone flat drain, Cardinal Health Canada Inc, 
Pointe-Claire, QC, Canada.
f. Hill’s Prescription Diet a/d, Hill’s Pet Nutrition, Topeka, Kan.
g. Humulin R, Eli Lilly Canada Inc, Toronto, ON, Canada.
h. Oxbow Carnivore Care, Oxbow Animal Health, Murdoch, Neb.
i. Sandosatin 100 µg/mL, Novartis Pharmaceuticals Canada 
Inc, Dorval, QC, Canada.
j. Guidewire-inserted chest tube, MILA International, Erlanger, Ky.
k. Burballa A, Ramis A, Martorell J. Chyloabdomen due to chron-
ic liver disease in a Djungarian hamster (Phodopus sungorus) 
(oral presentation). 1st Int Conf Avian Herpetol Exot Mamm 
Med, Wiesbaden, Germany, April 2013.
l. Huynh M, Exotics Department, Centre Hospitalier Vétérinaire 
Frégis, Arcueil, France: Personal communication, 2016.
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m. Fossum TW. Chylothorax: pathophysiology and treatment op-
tions (abst), in Proceedings. 24th Annu Am Coll Vet Intern Med 
Forum 2006. Available at: www.vin.com/doc/?id=3856265. 
Accessed Apr 16, 2016.
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